Trinity Biotech PLC ADR TRIB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TRIB is a good fit for your portfolio.
News
-
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
-
Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of Health
-
Trinity Biotech Announces Q2 2023 Financial Results
-
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results
-
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement
Trading Information
- Previous Close Price
- $0.48
- Day Range
- $0.43–0.54
- 52-Week Range
- $0.37–1.37
- Bid/Ask
- $0.43 / $0.53
- Market Cap
- $18.91 Mil
- Volume/Avg
- 10,646 / 35,250
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.27
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 398
- Website
- https://www.trinitybiotech.com
Valuation
|
Metric
|
TRIB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.27 |
Price/Cash Flow | — |
Price/Earnings
TRIB
Financial Strength
|
Metric
|
TRIB
|
|---|---|
Quick Ratio | 2.06 |
Current Ratio | 3.59 |
Interest Coverage | −3.11 |
Quick Ratio
TRIB
Profitability
|
Metric
|
TRIB
|
|---|---|
Return on Assets (Normalized) | −14.93% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −4.90% |
Return on Assets
TRIB
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Fyl | $191.5 Bil | |
DHR
| Danaher Corp | Cvmmqjj | $165.0 Bil | |
IQV
| IQVIA Holdings Inc | Jfcxtd | $39.1 Bil | |
IDXX
| IDEXX Laboratories Inc | Wwyjrn | $38.7 Bil | |
A
| Agilent Technologies Inc | Gnfk | $37.3 Bil | |
MTD
| Mettler-Toledo International Inc | Kvtsnjn | $23.7 Bil | |
ICLR
| Icon PLC | Csvlgp | $22.0 Bil | |
LH
| Laboratory Corp of America Holdings | Vvbrdw | $18.4 Bil | |
WAT
| Waters Corp | Tzmnb | $16.6 Bil | |
ILMN
| Illumina Inc | Dlnhsf | $16.2 Bil |